Insulet said total revenue for the 3 months ended March 31, 2025 was $569.0 million, an increase of $127.3 million (28.8%) compared with $441.7 million for the same period in the prior year. The company cited higher sales volume driven by its growing customer base as the primary factor in constant currency revenue growth of 29.8%.

1. 01

   Insulet said total revenue for the 3 months ended March 31, 2025 was $569.0 million, an increase of $127.3 million (28.8%) compared with $441.7 million for the same period in the prior year. The company cited higher sales volume driven by its growing customer base as the primary factor in constant currency revenue growth of 29.8%.

2. 02

   Insulet said gross margin for Q1 2025 was 71.9%, 240 basis points higher than 69.5% in the same period of the prior year, with improved manufacturing and supply chain efficiencies as the primary factor. The company expects full-year gross margin of approximately 71.0% and estimates the impact of tariffs at approximately 50 basis points.

3. 03

   Insulet said it issued $450 million in principal of 6.5% senior unsecured notes due April 2033 in March 2025 and repurchased $420 million in principal of Convertible Senior Notes in March and April. Net proceeds from the issuance for the 3 months were $440.7 million, of which $163.9 million was used to partially fund the repurchase.

4. 04

   Insulet said net cash provided by operating activities for Q1 2025 was $63.8 million, with a working capital outflow of $65.0 million as a partial offset. Free cash flow, reflecting capital expenditures of $12.3 million, was $51.5 million, compared with $65.5 million for the same period in the prior year.

Key figures

Quarter ended March 31, 2025

Revenue

$569M

Operating income

$89M

Net income

$35M

EPS

$0.50

Gross profit

$409M

Operating cash flow

$64M

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.